LivingGLP1
Condition P14A

Alcohol use disorder

People with alcohol use disorder or hazardous drinking.

2 randomized trials; 6 fitted analyses across 7 outcomes.

All outcomes

Each outcome is analyzed per time window and estimand, with doses kept apart (each dose) and pooled (each medicine). Analyses with too few connected trials are shown as descriptive.

Serious adverse events

O25
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsEach dose separately23Network meta-analysis
longest follow-upRecorded harmsDoses of a drug pooled23Network meta-analysis

Discontinuation due to adverse events

O26
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only
longest follow-upRecorded harmsEach dose separately12Descriptive only

Nausea

O27A
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsEach dose separately23Network meta-analysis
longest follow-upRecorded harmsDoses of a drug pooled23Network meta-analysis

Vomiting

O27B
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsDoses of a drug pooled23Network meta-analysis
longest follow-upRecorded harmsEach dose separately23Network meta-analysis

Diarrhea

O27C
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only
longest follow-upRecorded harmsEach dose separately12Descriptive only

Constipation

O27D
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only
longest follow-upRecorded harmsEach dose separately12Descriptive only

Acute pancreatitis

O29
Time windowEstimandTreatmentsTrialsNodesAnalysis
longest follow-upRecorded harmsEach dose separately12Descriptive only
longest follow-upRecorded harmsDoses of a drug pooled12Descriptive only